End of Content.
J Clin Pathways. 2025;11(6):38-42. INTRODUCTION In the health plan year 2025, health care stakeholders faced the lingering effects of the COVID-19 pandemic, a change in presidential and congressional party leadership, and artificial intelligence (AI)’s growing integration in health care. In addition, the rapid growth of the GLP-1 drug category overshadowed the...
F. Randy Vogenberg, PhD, FASHP J Clin Pathways. 2025;11(5):52-54. Stakeholder Positioning Across the Commercial and Government Health Insurance Landscape During the annual budget debate, Congress and state legislatures continued their advocacy and lobbying efforts to advance health care reform. Employers, manufacturers, providers, and consumer advocates descended upon statehouses and Congress to...
F. Randy Vogenberg, PhD, FASHP J Clin Pathways. 2025;11(5):55-56. There is a path forward for employer plans and manufacturers despite the health care sector surging with costs from unprecedented medical and technological breakthroughs. From artificial intelligence (AI)-assisted diagnostics and real-time clinical data platforms to the emergence of cell and gene therapies...
